PT  - JOURNAL ARTICLE
AU  - Dou, John F.
AU  - Schmidt, Rebecca J.
AU  - Volk, Heather E.
AU  - Nitta, Manon M.
AU  - Feinberg, Jason I.
AU  - Newschaffer, Craig J.
AU  - Croen, Lisa A.
AU  - Hertz-Picciotto, Irva
AU  - Fallin, M. Daniele
AU  - Bakulski, Kelly M.
TI  - Exposure to heavy metals <em>in utero</em> and autism spectrum disorder at age 3: A meta-analysis of two cohorts with enriched likelihood of autism
AID  - 10.1101/2023.11.21.23298827
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.11.21.23298827
4099  - http://medrxiv.org/content/early/2023/11/22/2023.11.21.23298827.short
4100  - http://medrxiv.org/content/early/2023/11/22/2023.11.21.23298827.full
AB  - Background Autism spectrum disorder (ASD) is a prevalent and heterogeneous neurodevelopmental disorder. Risk is attributed to genetic and prenatal environmental factors, though the environmental agents are incompletely characterized.Methods In Early Autism Risk Longitudinal Investigation (EARLI) and Markers of Autism Risk in Babies Learning Early Signs (MARBLES), two pregnancy cohorts with high likelihood of ASD, maternal urinary metals concentrations at two time points during pregnancy were measured using inductively coupled plasma mass spectrometry. At age three, clinicians assessed ASD with DSM-5 criteria. Using multivariable log binomial regression, we examined each metal for association with ASD status, adjusting for gestational age at urine sampling, child sex, maternal age, and maternal education, and meta-analyzed across the two cohorts.Results In EARLI (n=170) 17.6% of children were diagnosed with ASD, and an additional 43.5% were classified as having other non-neurotypical development (Non-TD). In MARBLES (n=156), 22.7% were diagnosed with ASD, while an additional 11.5% had Non-TD. In earlier pregnancy metals measures, having cadmium concentration over the level of detection was associated with 1.78 (1.19, 2.67) times higher risk of ASD, and 1.43 (1.06, 1.92) times higher risk of Non-TD. A doubling of early pregnancy cesium concentration was marginally associated with 1.81 (0.95, 3.42) times higher risk of ASD, and 1.58 (0.95, 2.63) times higher risk of Non- TD.Conclusion Exposure in utero to elevated levels of cadmium and cesium, as measured in maternal urine collected during pregnancy, was associated with increased risk of developing ASD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for the EARLI study was provided by the National Institutes of Health (R01ES016443, R24ES030893) and Autism Speaks (003953). Funding for the MARBLES study was provided by the National Institutes of Health (R01ES020392, R01ES028089, R/U24ES028533, and P01ES011269) and the United States Environmental Protection Agency Science to Achieve Results program (#RD-83329201). Funding for metals measures and this work was supported by the National Institutes of Health (R01ES025531). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Human Subjects IRB of the University of Michigan gave ethical approval for this work. Human Subjects IRB of the University of California Davis gave ethical approval for this work. Human Subjects IRB of Kaiser Permanente Northern California gave ethical approval for this work. Human Subjects IRB of Drexel University gave ethical approval for this work. Human Subjects IRB of the Johns Hopkins University gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData used in this manuscript is publicly available through the National Institute of Mental Health Data Archive (EARLI cohort repository: 1600, MARBLES cohort repository: 1946, EARLI/MARBLES metals repository: 2462) and through data requests to the Principal Investigators of cohorts (EARLI: MDF, MARBLES: RJS).